Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: A case-control study

Lancet

Volumn 356, Issue 9237, 2000, Pages 1219-1223

  Zornberg, Gwen L ^a   Jick, Hershel ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; PHENOTHIAZINE DERIVATIVE; THIORIDAZINE; THIOXANTHENE DERIVATIVE;

ADULT; AGE DISTRIBUTION; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EXPOSURE; DRUG POTENCY; DRUG USE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PSYCHOSIS; RISK ASSESSMENT; RISK FACTOR; THROMBOEMBOLISM; TREATMENT OUTCOME; VEIN DISEASE;

EID: 0034619072     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02784-7     Document Type: Article

References (23)

1. Antipsychotic medication
2. Mortality in current and former users of clozapine
3. Pulmonary embolus possibly associated with clozapine treatment
4. Association of venous thromboembolism and clozapine
5. Clozapine and sudden death
6. Clozapine and myocarditis
7. Deep-vein thrombosis with antipsychotic drugs
8. Left pulmonary artery thrombosis in chlorpromazine-induced lupus
9. Thromboembolic complications in neuroleptic treatment
10. Thromboembolische komplikationen bei neuro- und thymoleptischer behandlung
11. Factor V Leiden and fatal pulmonary embolism
12. Sudden death during treatment with phenothiazine derivatives
13. Sudden death in a patient taking haloperidol
14. Neuroleptic-related sudden death (proven or a mere hypothesis?)
15. Sudden death and flupenthixol decanoate
16. A database worth saving
17. The UK general practice research database
18. Use of the UK General Practice Research Database for pharmacoepidemiology
19. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom
20. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom
21. The platelet as a model for investigating the clinical efficacy of centrally acting drugs: Relations between platelet aggregation and clinical condition in schizophrenics treated with chlorpromazine
22. The relationship between changes in 5-HT induced platelet aggregation and clinical state in patients treated with fluphenazine
23. Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: Absence of thrombosis